Global Cardiac Output Monitoring Device Market Size Likely to Grow at a CAGR of 7.9% By 2035

The market for the cardiac output monitoring device is expected to have a CAGR of 7.9% in 2026-2035 and reach a market size of USD 1.24 billion by 2026.The cardiac output monitoring device market is projected to reach USD 1.24 billion by 2026 and USD 2.89 billion by 2035 at a CAGR of 7.9% from 2026 to 2035.

Cardiac Output Monitoring Device Market Revenue and Trends

The global cardiac output monitoring devices market consists of advanced medical devices that are employed to measure the flow of blood pumped by the heart each minute, which includes invasive, minimally invasive and non-invasive devices based on thermodilution, pulse contour, bioreactance, Doppler and bioimpedance technologies. Such devices play a vital role in the operating room, intensive care unit, and emergency room when it comes to fluid therapy, medication delivery, and patient stabilization.

Worldwide, the cardiac output monitoring device market is steadily expanding due to the prevalence of cardiovascular diseases, the number of cardiac surgeries and admissions to critical care units, the growing trend toward minimally and non-invasive monitoring, and the growing geriatric population, as well as technological advances in accuracy and usability worldwide.

What are the Factors That Have a Significant Contribution to the Growth of the cardiac output monitoring device market?

High demand for reliable hemodynamic monitoring solutions as a core component of critical care and during surgery and anesthesia has driven worldwide adoption, especially in patients at high risk for heart failure and cardiovascular disease who require precise fluid management. Consistency in use for optimizing surgical outcomes in major surgery and in patients in the Intensive Care Unit (ICU) are cited as advantages to the market. With a focus on early intervention and individualised treatment, clinicians are looking for advanced cardiac output monitoring devices that can be integrated with the latest critical care protocols, and are capable of improving patient outcomes.

Technological advancements have given rise to highly accurate, more convenient, patient-friendly and real-time data driven systems that are more easily integrated with patient monitoring platforms, enhancing patient comfort, ease of use and clinical decision making.

Segment Insight

By Product Type

As of 2025, non-invasive cardiac output monitoring devices accounted for the largest market share of cardiac output monitoring devices; this share was driven by the fact that they are easier to use, provide patient safety, do not pose an infection risk, and are increasingly being preferred over invasive devices, especially in the perioperative and critical care setting. Clinicians who demand continuous, accurate monitoring without procedural complications are seeing significant growth in the development of innovations such as bioreactance and Doppler technologies that provide reliable monitoring and integrate into the existing monitoring environment—the most important for achieving optimal hemodynamic management and improved patient outcomes, according to anesthesiologists and intensivists.

By Distribution Channel

Direct sales and hospital pharmacies/distributors account for the biggest market share, also being the main pathway to purchase devices, receive technical training, technical support, and after-sale service. These channels are the preferred choice for healthcare institutions that have high acuity patient care requirements for advanced hemodynamic monitoring, offering expert installation guidance, staff education and a reliable supply for hospitals, cardiac centers and critical care facilities.

Regional Insights

The cardiac output monitoring device market is expected to be led by North America, as it has a high prevalence of cardiovascular diseases, has advanced healthcare infrastructure, has high adoption of innovative cardiac output monitoring technologies, and has large investments in cardiac critical care. The area has been the recipient of favourable reimbursement policies, the presence of some of the leading manufacturers and early adoption of minimally and non-invasive systems which are driving continuous demand and market stability.

The rising prevalence of cardiovascular diseases, growing healthcare infrastructure, growing number of surgeries, growing advanced benefits of cardiac output monitoring devices, and overall growing awareness of advanced benefits of cardiac output monitoring devices are the major factors contributing to the fastest growth of cardiac output monitoring device market in Asia Pacific region over the period. The rising expenditure on healthcare, the government's attention to the improvement of cardiac care, and the manufacturing capabilities in these countries are boosting the adoption of cost-effective and advanced devices in countries such as China, India, and Japan. Other factors such as aging population, urbanisation and improved diagnostics will further drive market growth in Asia Pacific.

Report Scope

Recent Developments

• In 2025: Edwards Lifesciences added new capabilities to its Acumen IQ and FloTrac systems that take hemodynamic management (HH) into the perioperative and critical care environment, with better predictive algorithms and seamless integration for non-invasive cardiac output (NICO) monitoring.

List of the prominent players in the Cardiac Output Monitoring Device Market:

• Edwards Lifesciences Corporation

• ICU Medical Inc. (LiDCO)

• Philips Healthcare

• GE HealthCare Technologies Inc.

• Getinge AB (PULSION Medical Systems / PiCCO)

• Mindray Medical International Limited

• Nihon Kohden Corporation

• Baxter International Inc. (Cheetah Medical / NICOM)

• Deltex Medical Group plc

• Tensys Medical Inc.

• Others

The Cardiac Output Monitoring Device Market is segmented as follows:

By Product Type

• Invasive Cardiac Output Monitoring Devices

  • Pulmonary Artery Catheter (PAC) Systems

  • Continuous Cardiac Output PAC Systems

  • Right Heart Catheterization Systems

• Minimally Invasive Cardiac Output Monitoring Devices

  • Arterial Pulse Contour Analysis Systems

  • Transpulmonary Thermodilution Systems

  • Esophageal Doppler Monitoring Systems

  • Lithium Dilution Cardiac Output Systems

• Non-Invasive Cardiac Output Monitoring Devices

  • Bioimpedance Cardiography (ICG) Systems

  • Bioreactance Monitoring Systems

  • Non-Invasive PPG-Based Cardiac Output Monitors

  • Transthoracic Echocardiography-Based Systems

  • Wearable & Ambulatory Hemodynamic Monitors

By Technology

• Thermodilution

  • Intermittent Bolus Thermodilution (PAC)

  • Continuous Thermodilution (Continuous CO PAC)

  • Transpulmonary Thermodilution (PiCCO, EV1000)

• Pulse Contour Analysis

  • Calibrated Pulse Contour Analysis (PiCCO, LiDCO Plus)

  • Uncalibrated Pulse Contour Analysis (FloTrac/Vigileo, LiDCO Rapid)

  • Volume Clamp / Vascular Unloading Technique (ClearSight)

• Fick Method

  • Direct Fick Method (Oxygen Consumption Measurement)

  • Indirect Fick Method (CO₂ Rebreathing)

• Echocardiography-Based Monitoring

  • Transthoracic Echocardiography (TTE) Cardiac Output

  • Transesophageal Echocardiography (TEE) Cardiac Output

  • Esophageal Doppler Monitoring (EDM)

  • Automated Stroke Volume Estimation (AI-Enhanced Echo)

• Bioimpedance & Bioreactance

  • Thoracic Electrical Bioimpedance (TEB)

  • Bioreactance (Phase Shift Analysis)

  • Whole-Body Bioimpedance Cardiography

• Other Technologies

  • Dye Dilution Method

  • Arterial Pressure Waveform Analysis (APWA)

  • Photoplethysmography (PPG)-Based CO Estimation

  • Ballistocardiography

By End Use

• Hospitals & ICUs

  • Cardiac Surgical Intensive Care Units (CSICUs)

  • Medical-Surgical ICUs & Mixed Critical Care Units

  • Cardiac Catheterization Laboratories

  • Emergency Departments & Resuscitation Bays

  • Operative & Post-Anesthesia Care Units (PACUs)

• Ambulatory Surgical Centers

  • High-Risk Ambulatory Surgical Procedures

  • Outpatient Cardiac Monitoring Programs

• Cardiac Care Centers

  • Heart Failure Clinics & Remote Monitoring Programs

  • Cardiac Rehabilitation Centers

  • Electrophysiology & Structural Heart Programs

• Other End Users

  • Military & Trauma Medical Facilities

  • Home Health & Telehealth Platforms

  • Academic & Clinical Research Institutions

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America